Samantha Wilkinson (@EO_SamWilkinson) header
Samantha Wilkinson (@EO_SamWilkinson) profile picture

Commissioning Editor of Expert Opinion on Pharmacotherapy and Expert Opinion on Emerging Drugs. Views expressed are my own.

Joined May 2015
Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)Photo by Samantha Wilkinson (@EO_SamWilkinson)
Nintedanib for the treatment of idiopathic pulmonary fibrosis https://nitter.gq/t.co/nwrcxgpm8m #Pharmacotherapy
1
Will tyrosine kinase inhibitors be part of the treatment armamentarium for CML in the future? https://nitter.gq/t.co/iDwArQftmp #Pharmacotherapy
1
#Pharmacotherapy and treatment options for HIV-associated nephropathy https://nitter.gq/t.co/8HrunY3jVa
2
Advances in the treatment of HIV/HCV coinfection in adults https://nitter.gq/t.co/s6Wxt9TNCb #Pharmacotherapy
1
Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection https://nitter.gq/t.co/b8Glsns8iu #Pharmacotherapy
Efficacy and safety of sotagliflozin in treating diabetes type 1 https://nitter.gq/t.co/xlutMJK1sT #Pharmacotherapy
Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor #pharmacotherapy https://nitter.gq/t.co/fdSs6jvBbN
Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study https://nitter.gq/t.co/IgnDlw5wLg #Pharmacotherapy
Cardiovascular outcomes with canagliflozin – is it on the CANVAS? https://nitter.gq/t.co/SNHd0eyEcy #Pharmacotherapy
Effect of a sequential treatment combining abaloparatide and alendronate for the management of postmenopausal osteoporosis https://nitter.gq/t.co/0v8g20Tfe0 #Pharmacotherapy
Triple fixed inhaled therapy in frequent chronic obstructive pulmonary disease exacerbators: potential advantages for various degrees of airways obstruction https://nitter.gq/t.co/sGXebcJtBH #Pharmacotherapy
1
Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis https://nitter.gq/t.co/N4ZTSs9N3A #Pharmacotherapy
An update on new and emerging therapies for cystic fibrosis https://nitter.gq/t.co/Iz9yN8eqF8 #EmergingDrugs
Triplet vs. doublet drug regimens for managing multiple myeloma https://nitter.gq/t.co/fW9v3J08EW #Pharmacotherapy
Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline https://nitter.gq/t.co/pC4YDcBZE4 #EmergingDrugs
An update on emerging drugs for fibromyalgia treatment https://nitter.gq/t.co/w1a5HabcMo #EmergingDrugs
Emerging drugs for the treatment of gastrointestinal stromal tumour https://nitter.gq/t.co/vYCQZRQqnB #EmergingDrugs
#Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity https://nitter.gq/t.co/HyQgMDBOXD
Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage https://nitter.gq/t.co/8vrxu0kBC6 #Pharmacotherapy
Menstrual migraine: a review of current and developing pharmacotherapies for women https://nitter.gq/t.co/Bc9GJyI9Pl #Pharmacotherapy